相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estimating the Burden of Total Knee Replacement in the United States
Alexander M. Weinstein et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2013)
ESTIMATING INCIDENCE AND PREVALENCE OF OSTEOARTHRITIS (OA) IN ALBERTA USING ADMINISTRATIVE CLAIMS DATA
D. A. Marshall et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Implementation of the simplified stochastic model of ageing for longitudinal osteoarthritis data assessment
Michael Korostishevsky et al.
ANNALS OF HUMAN BIOLOGY (2012)
System Dynamics to Model the Unintended Consequences of Denying Payment for Venous Thromboembolism after Total Knee Arthroplasty
Mathias Worni et al.
PLOS ONE (2012)
Modeling the demand for long-term care services under uncertain information
Teresa Cardoso et al.
HEALTH CARE MANAGEMENT SCIENCE (2012)
Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans
Elena Losina et al.
ANNALS OF INTERNAL MEDICINE (2011)
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Value of Information in the Osteoarthritis Setting Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
Nicholas Latimer et al.
PHARMACOECONOMICS (2011)
Facilitating stroke care planning through simulation modelling
Steffen Bayer et al.
HEALTH INFORMATICS JOURNAL (2010)
Development of a population-based microsimulation model of osteoarthritis in Canada
J. A. Kopec et al.
OSTEOARTHRITIS AND CARTILAGE (2010)
Cost-effectiveness of Total Knee Arthroplasty in the United States Patient Risk and Hospital Volume
Elena Losina et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective
Louis Bessette et al.
JOURNAL OF MEDICAL ECONOMICS (2009)
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis
Nicholas Latimer et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States
Reva C. Lawrence et al.
ARTHRITIS AND RHEUMATISM (2008)
Chronic illness in a complex health economy: the perils and promises of downstream and upstream reforms
Jack Homer et al.
SYSTEM DYNAMICS REVIEW (2007)
A taxonomy of model structures for economic evaluation of health technologies
Alan Brennan et al.
HEALTH ECONOMICS (2006)
Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population?
RA Elliott et al.
RHEUMATOLOGY (2006)
Transitions to mobility difficulty associated with lower extremity osteoarthritis in high functioning older women: Longitudinal data from the Women's Health and Aging Study II
SM Ling et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Classifying health-related quality of life outcomes of total hip arthroplasty
M Xu et al.
BMC MUSCULOSKELETAL DISORDERS (2005)
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis
A Maetzel et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis
BMR Spiegel et al.
ANNALS OF INTERNAL MEDICINE (2003)
The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis
CC Kamath et al.
VALUE IN HEALTH (2003)
A simulation model for estimating direct costs of type 1 diabetes prevention
J Hahl et al.
PHARMACOECONOMICS (2003)
Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland
JVM Chancellor et al.
PHARMACOECONOMICS (2001)
分享论文
